Furosemide Injection
Baxter Healthcare · Available
Open FDA's page for this record- Update type
- Reverified
- Initial posting date
- 04/07/2020
- Package NDC
- 36000-284-25
- Generic name
- Furosemide Injection
- Contact info
- 888-229-0001
- Availability
- Available
- Update date
- 11/18/2026
- Dosage form
- Injection
- Presentation
- Furosemide, Injection, 10 mg/1 mL (NDC 36000-284-25)
- Company name
- Baxter Healthcare
- Status
- Current
- Therapeutic category
- Cardiovascular
- Harmonized identifiers (openFDA)
- Application number
- ANDA202747
- Brand name
- FUROSEMIDE
- Generic name
- FUROSEMIDE
- Manufacturer name
- Baxter Healthcare Corporation
- Product NDC
- 36000-284, 36000-063, 36000-064, 36000-065, 36000-282, 36000-283
- Product type
- HUMAN PRESCRIPTION DRUG
- Route
- INTRAVENOUS
- Substance name
- FUROSEMIDE
- RxCUI
- 1719286, 1719290, 1719291
- SPL ID
- b4c1ae97-0f6c-4ae1-858a-4e0ab8f1ce53
- SPL set ID
- c71371a7-75c5-45b8-b762-8d782d4c71bc
- Package NDC
- 36000-063-05, 36000-064-05, 36000-065-05, 36000-282-25, 36000-283-25, 36000-284-25
- Nui
- N0000175366, N0000175590
- Pharm class pe
- Increased Diuresis at Loop of Henle [PE]
- Pharm class epc
- Loop Diuretic [EPC]
- UNII
- 7LXU5N7ZO5
